| CPC A61K 40/428 (2025.01) [A61K 40/19 (2025.01); A61P 35/00 (2018.01); C12N 5/0639 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2304 (2013.01); C12N 2501/25 (2013.01); C12N 2501/51 (2013.01); C12N 2501/52 (2013.01); C12N 2502/30 (2013.01)] | 17 Claims |
|
1. A novel dendritic cell preparation, comprising PD-L1 negative dendritic cells and dendritic cells with CD40 agonists bound to the cell surface, wherein the surface of PD-L1 negative dendritic cells in the preparation is bound to PD-L1 antibodies.
|